Lamisil and Solu-medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamisil (terbinafine hydrochloride) and Solu-medrol (methylprednisolone sodium succinate). Common drug interactions include acute respiratory distress syndrome among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Lamisil and Solu-medrol. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.

On Jul, 20, 2026

45 people who take Lamisil and Solu-medrol together, and have interactions are studied.

Lamisil and Solu-medrol drug interactions.

What are the common drug interactions of Lamisil and Solu-Medrol, by gender? *:

female:

Acute respiratory distress syndrome
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anisocytosis (patient's red blood cells are of unequal size)
Anxiety
Asthenia (weakness)
Beta 2 microglobulin increased
Blood calcium decreased
Blood glucose increased
Blood lactate dehydrogenase increased
Blood triglycerides increased

male:

Cardiac failure congestive
Dyspnoea (difficult or laboured respiration)
Oxygen saturation decreased
Respiratory failure (inadequate gas exchange by the respiratory system)
Anaphylactic reaction (serious allergic reaction)
Antasthmatic drug level above therapeutic
Arteriosclerosis (thickening and hardening of arteries)
Arthralgia (joint pain)
Asthenia (weakness)
Blood immunoglobulin e increased

What are the common drug interactions of Lamisil and Solu-Medrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Abdominal pain upper
Acute respiratory distress syndrome
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anisocytosis (patient's red blood cells are of unequal size)
Anxiety
Asthenia (weakness)
Back pain
Beta 2 microglobulin increased
Blood calcium decreased
Blood glucose increased

40-49:

Renal failure (kidney dysfunction)
Abdominal discomfort
Abdominal distension
Abdominal hernia
Abdominal pain upper
Acute respiratory distress syndrome
Acute respiratory failure
Adrenal disorder
Agitation (state of anxiety or nervous excitement)
Alopecia (absence of hair from areas of the body)

50-59:

Headache (pain in head)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Heart rate increased
Palpitations (feelings or sensations that your heart is pounding or racing)
Abdominal discomfort
Actinomyces test positive
Anaphylactic reaction (serious allergic reaction)
Anxiety
Arteriosclerosis (thickening and hardening of arteries)
Ataxia (loss of full control of bodily movements)

60+:

Dyspnoea (difficult or laboured respiration)
Interstitial lung disease
Respiratory failure (inadequate gas exchange by the respiratory system)
Antasthmatic drug level above therapeutic
Asthenia (weakness)
Blood immunoglobulin e increased
Death
Dyspnoea exertional (breathlessness or shortness of breath)
Fall
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 15.56%
Tinea Infection (fungal skin infection): 6 people, 13.33%
Diabetes: 6 people, 13.33%
Polychondritis (progressive inflammation of cartilage and other connective tissue): 5 people, 11.11%
Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 4 people, 8.89%
High Blood Cholesterol: 4 people, 8.89%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 3 people, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 6.67%
Arrhythmias (irregular heartbeat): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and Solu-medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously